138 related articles for article (PubMed ID: 31387829)
1. Targeting inhibitors of apoptosis in oral squamous cell carcinoma in vitro.
Scheurer MJJ; Seher A; Steinacker V; Linz C; Hartmann S; Kübler AC; Müller-Richter UDA; Brands RC
J Craniomaxillofac Surg; 2019 Oct; 47(10):1589-1599. PubMed ID: 31387829
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic effects of SMAC-mimetic compound LCL161 in head and neck cancer cell lines.
Brands RC; Herbst F; Hartmann S; Seher A; Linz C; Kübler AC; Müller-Richter UDA
Clin Oral Investig; 2016 Dec; 20(9):2325-2332. PubMed ID: 26846923
[TBL] [Abstract][Full Text] [Related]
3. Sensitization of head and neck squamous cell carcinoma to apoptosis by combinational SMAC mimetic and Fas ligand-Fc treatment in vitro.
Brands RC; Scheurer MJJ; Hartmann S; Seher A; Freudlsperger C; Moratin J; Linz C; Kübler AC; Müller-Richter UDA
J Craniomaxillofac Surg; 2020 Jul; 48(7):685-693. PubMed ID: 32507671
[TBL] [Abstract][Full Text] [Related]
4. LCL161, a SMAC-mimetic, Preferentially Radiosensitizes Human Papillomavirus-negative Head and Neck Squamous Cell Carcinoma.
Yang L; Kumar B; Shen C; Zhao S; Blakaj D; Li T; Romito M; Teknos TN; Williams TM
Mol Cancer Ther; 2019 Jun; 18(6):1025-1035. PubMed ID: 31015310
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis-sensitizing activity of birinapant in head and neck squamous cell carcinoma cell lines.
Brands RC; Scheurer MJJ; Hartmann S; Seher A; Kübler AC; Müller-Richter UDA
Oncol Lett; 2018 Mar; 15(3):4010-4016. PubMed ID: 29467909
[TBL] [Abstract][Full Text] [Related]
6. Smac mimetic compound LCL161 sensitizes esophageal carcinoma cells to radiotherapy by inhibiting the expression of inhibitor of apoptosis protein.
Qin Q; Zuo Y; Yang X; Lu J; Zhan L; Xu L; Zhang C; Zhu H; Liu J; Liu Z; Tao G; Dai S; Zhang X; Ma J; Cai J; Sun X
Tumour Biol; 2014 Mar; 35(3):2565-74. PubMed ID: 24170321
[TBL] [Abstract][Full Text] [Related]
7. LCL161 enhances expansion and survival of engineered anti-tumor T cells but is restricted by death signaling.
Afsahi A; Silvestri CM; Moore AE; Graham CF; Bacchiochi K; St-Jean M; Baker CL; Korneluk RG; Beug ST; LaCasse EC; Bramson JL
Front Immunol; 2023; 14():1179827. PubMed ID: 37138866
[TBL] [Abstract][Full Text] [Related]
8. LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC.
Yang C; Wang H; Zhang B; Chen Y; Zhang Y; Sun X; Xiao G; Nan K; Ren H; Qin S
J Exp Clin Cancer Res; 2016 Sep; 35(1):158. PubMed ID: 27737687
[TBL] [Abstract][Full Text] [Related]
9. Inhibitor of apoptosis proteins as therapeutic targets in multiple myeloma.
Ramakrishnan V; Painuly U; Kimlinger T; Haug J; Rajkumar SV; Kumar S
Leukemia; 2014 Jul; 28(7):1519-28. PubMed ID: 24402161
[TBL] [Abstract][Full Text] [Related]
10. Induction of Necroptosis in Human Breast Cancer Drug-Resistant Cells by SMAC Analog LCL161 After Caspase Inhibition Requires RIP3.
Jin G; Liu Y; Xu P; Jin G
Pharmazie; 2019 Jun; 74(6):363-368. PubMed ID: 31138375
[TBL] [Abstract][Full Text] [Related]
11. Cotreatment with Smac mimetics and demethylating agents induces both apoptotic and necroptotic cell death pathways in acute lymphoblastic leukemia cells.
Gerges S; Rohde K; Fulda S
Cancer Lett; 2016 May; 375(1):127-132. PubMed ID: 26944210
[TBL] [Abstract][Full Text] [Related]
12. The radiosensitizing activity of the SMAC-mimetic, Debio 1143, is TNFα-mediated in head and neck squamous cell carcinoma.
Matzinger O; Viertl D; Tsoutsou P; Kadi L; Rigotti S; Zanna C; Wiedemann N; Vozenin MC; Vuagniaux G; Bourhis J
Radiother Oncol; 2015 Sep; 116(3):495-503. PubMed ID: 26096848
[TBL] [Abstract][Full Text] [Related]
13. Sensitization of neuroblastoma for vincristine-induced apoptosis by Smac mimetic LCL161 is attended by G2 cell cycle arrest but is independent of NFκB, RIP1 and TNF-α.
Langemann D; Trochimiuk M; Appl B; Hundsdoerfer P; Reinshagen K; Eschenburg G
Oncotarget; 2017 Oct; 8(50):87763-87772. PubMed ID: 29152118
[TBL] [Abstract][Full Text] [Related]
14. [Effects of LCL161, a Smac mimetic on the proliferation and apoptosis in hepatocellular carcinoma cells].
Ren K; Ma L; Chong D; Zhang Z; Zhou C; Liu H; Zhao S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Sep; 41(9):898-904. PubMed ID: 27640787
[TBL] [Abstract][Full Text] [Related]
15. Targeting inhibitor of apoptosis proteins (IAPs) enhances susceptibility of oral squamous carcinoma cells to cisplatin.
Gao T; Magnano S; Rynne A; O'Kane L; Barroeta PH; Zisterer DM
Exp Cell Res; 2024 Apr; 437(1):113995. PubMed ID: 38490621
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of IAP inhibitor LCL161 and paclitaxel on hepatocellular carcinoma cells.
Tian A; Wilson GS; Lie S; Wu G; Hu Z; Hebbard L; Duan W; George J; Qiao L
Cancer Lett; 2014 Sep; 351(2):232-41. PubMed ID: 24976294
[TBL] [Abstract][Full Text] [Related]
17. Smac mimetic primes apoptosis-resistant acute myeloid leukaemia cells for cytarabine-induced cell death by triggering necroptosis.
Chromik J; Safferthal C; Serve H; Fulda S
Cancer Lett; 2014 Mar; 344(1):101-109. PubMed ID: 24184825
[TBL] [Abstract][Full Text] [Related]
18. Effects of FasL expression in oral squamous cell cancer.
Fang L; Sun L; Hu FF; Chen QE
Asian Pac J Cancer Prev; 2013; 14(1):281-5. PubMed ID: 23534738
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel synergistic induction of cell death by Smac mimetic and HDAC inhibitors in acute myeloid leukemia cells.
Steinwascher S; Nugues AL; Schoeneberger H; Fulda S
Cancer Lett; 2015 Sep; 366(1):32-43. PubMed ID: 26028172
[TBL] [Abstract][Full Text] [Related]
20. Smac mimetics LCL161 and GDC-0152 inhibit osteosarcoma growth and metastasis in mice.
Shekhar TM; Burvenich IJG; Harris MA; Rigopoulos A; Zanker D; Spurling A; Parker BS; Walkley CR; Scott AM; Hawkins CJ
BMC Cancer; 2019 Sep; 19(1):924. PubMed ID: 31521127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
